Influence of genetic polymorphisms of CYP1A1 and GSTM1 on the urinary levels of 1-hydroxypyrene

Toxicology Letters

Volumn 144, Issue 1, 2003, Pages 27-34

  Apostoli, P ^a   Neri, G ^a   Lucas, D ^b   Manno, M ^c   Berthou, F ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

1 Hydroxypyrene; Cytochrome P450 1A1; Glutathione S transferase M1; Polycyclic aromatic hydrocarbons

Indexed keywords

1 HYDROXYPYRENE; CYTOCHROME P450 1A1; CYTOCHROME P450 2A; CYTOCHROME P450 2B; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; XENOBIOTIC AGENT;

ADULT; AIRBORNE PARTICLE; BIOTRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; EMPLOYEE; FLUOROMETRY; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRON AND STEEL INDUSTRY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WORKER;

EID: 0041622961     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(03)00227-3     Document Type: Conference Paper

References (31)

1. Alexandrie A.K., Warholm M., Carstensen U., Axmon A., Agmar L., Levin J.O., Ostman C., Rannung A. CYP1A1 and GSTM1 polymorphisms affect urinary 1-OH-P levels after PAH exposure. Carcinogenesis. 21:(4):2000;669-676.
2. Ambrosone C.B., Freudenheim J.L., Graham S., Marshall J.R., Vena J.E., Brasure J.R., Laughlin R., Nemoto T., Michalek A.M., Harrington A., Ford T., Shields P. Cytochrome P450 1A1 and glutathione-S-transferase M1 genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 55:(16):1995;3483-3485.
3. Boffetta P., Muggenburg B.A., Scott G.G., Lewis J.L., Pyon K.H., Dahl A.R. Local metabolism in lung airways increases the uncertainty of pyrene as a biomarker of polycyclic aromatic hydrocarbon exposure. Carcinogenesis. 19:(3):1998;493-500.
4. Crafts F., Taioli E., Trachman J., Cosma G.N., Currie D., Toniolo P., Garte S.J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis. 15:1994;2961-2963.
5. Elovaara E. Oxidation of pyrene in human liver and lungs. Hum. Exp. Toxicol. 14:1995;821-825.
6. Gabbani, G., Nardini, M., Marchioro, M., Clonfero, E., 1996. Effect of the metabolic genotypes GSTM1 and NAT2 on the urinary excretion of mutagens. In: Proceedings of the First National Meeting on Polycyclic Aromatic Hydrocarbons in the Living and Occupational Environment, Gargnano, Brescia, pp. 277-282.
7. Georgiadis P., Kyrtopoulos S.A. Molecular epidemiological approaches to the study of the genotoxic effects of urban air pollution. Mutat. Res. 428:(1-2):1999;91-98.
8. Golka K., Reckwitz T., Kempkes M., Cascorbi I., Blaskewicz M., Reich S.E., Roots I., Soekeland J., Schulze H., Bolt H.M. N-Acetyltransferase-2 (NAT2) and glutathione-S-transferase M1 (GSTM1) in bladder cancer patients in a highly industrialized area. Int. J. Occup. Environ. Health. 3:(2):1997;105-110.
9. Hansen A.M., Omland O., Poulsen O.M., Sherson D., Sigsgaard T., Christensen J.M., Overgaard E. Correlation between work process-related exposure to polycyclic aromatic hydrocarbons and urinary levels of alpha-naphthol, beta-naphthylamine and 1-hydoxypyrene in iron foundry workers. Int. Arch. Occup. Environ. Health. 65:1994;385-394.
10. Hayashi S., Watanabe J., Nakachi K., Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme-binding region of the human cytochrome P450 IA1 gene. J. Biochem. 110:(3):1991;407-411.
11. Hemminki K., Dickey C., Karlsson S., Bell D., Hsu Y., Tsai W.Y., Mooney L.V.A., Savela K., Perera F.P. Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis. 18:(2):1997;345-350.
12. Hirvonen A., Husgavle-Pursiainen K., Karjalainen A., Antila S., Vainio H. Point mutation MspI and Ile/Val polymorphism close linked in the CYP1A1 gene: lack of association with susceptibility of lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prev. 1:1992;485-489.
13. IARC (International Agency for Research on Cancer), 1983. Evaluation of carcinogenic risk of chemical to humans. Polynuclear Aromatic Compounds. Part 1: Chemical, Environmental and Experimental Data, Vol. 32, Lyon.
14. IARC (International Agency for Research on Cancer), 1984. Evaluation of carcinogenic risk of chemicals to humans. Polynuclear Aromatic Compounds. Part 3: Industrial Exposure in Aluminium Production, Coal Gasification, Coke Production and Iron and Steel Founding, Vol. 34, Lyon.
15. Ingelman-Sundberg M., Johansson I., Persson I., Jue Q.J., Dahl M.L., Bertilsson L., Sjoqvist F. Genetic polymorphism of cytochrome P450: interethnic differences and relationship to incidence of lung cancer. Pharmacogenetics. 2:1992;264-271.
16. Jongeneelen F.J. Biological monitoring of environmental exposure to polycyclic aromatic hydrocarbons: 1-OH-P in urine of people. Toxicol. Lett. 72:1994;205-211.
17. Jongeneelen F.J., Anzion R.B.M., Henderson P.T. Determination of hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. J. Chromatogr. 413:1987;227-232.
18. Kang D., Rothman N., Hun Cho S., Schwartz B., Strickland P.T. Association of exposure to polycyclic aromatic hydrocarbons (estimated from job category) with concentration of 1-OH-P glucoronide in urine from workers at a steel plant. Occup. Environ. Med. 52:1995;593-599.
19. Ketterer B. The human glutathione-S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Perspect. 98:1992;87-94.
20. Lucas D., Menez C., Floch F., Gourlaouen Y., Sparfel O., Joannet I., Bodenez P., Jezequel J., Gouerou H., Berthou F., Bardou L.G., Menez J.F. Cytochromes P450 2E1 and P450 1A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians. Alcohol. Clin. Exp. Res. 20:(6):1996;1033-1037.
21. Mastrangelo G., Fadda E., Marzia V. Polycyclic aromatic hydrocarbons and cancer in man. Environ. Health Perspect. 104:(11):1996;1166-1170.
22. Merlo F., Andreassen A., Weston A., Pan C.F., Haugen A., Valerio F., Reggiardo G., Fontana V., Garte S., Puntoni R., Abbondandolo A. Urinary excretion of 1-OH-P as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomarkers Prev. 7:1998;147-155.
23. Nan H.M., Kim H., Lim H.S., Choi J.K., Kawamoto T., Kang J.W., Lee C.H., Kim J.D., Kwon E.H. Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-OH-P and 2-naphthol concentrations. Carcinogenesis. 22:(5):2001;787-793.
24. Nebert D.W., Petersen D.D., Puga A. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion product and dioxin. Pharmacogenetics. 1:1991;68-78.
25. Ovrebo S., Ryberg D., Haugen A., Leira H.L. Glutathione-S-transferase M1 and P1 genotypes and urinary excretion of 1-OH-P in coke-oven workers. Sci. Total Environ. 220:1998;25-31.
26. Pan G., Hanaoka T., Yamano Y., Hara K., Ichiba M., Wang Y., Zhang J., Feng Y., Shujuan Z., Guan D., Gao G., Liu M., Takahashi K. A study of multiple biomarkers in coke-oven workers: a cross-sectional study in China. Carcinogenesis. 19:(11):1998;1963-1968.
27. Pavanello S., Clonfero E. Biomarkers of genotoxic risk and metabolic polymorphism. Med. Lav. 91:2000;431-469.
28. Quinones L., Berthou F., Varela N., Simon B., Gil L., Lucas D. Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations. Cancer Lett. 141:(1-2):1999;167-171.
29. Strickland P., Kang D. Urinary 1-OH-P and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol. Lett. 108:(2-3):1999;191-199.
30. Wu M.T., Huang S.L., Ho C.K., Yeh Y.F., Christiani D.C. Cytochrome P450 1A1 MspI polymorphism and urinary-1-hydroxypyrene concentrations in coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 7:1998;823-829.
31. Xu X., Kelsey K.T., Wiencke J.K., Wain J.C., Christiani D.C. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 5:1996;687-692.